Applied DNA Sciences, Inc. (UDJP.F)
Chart Events
Performance Outlook
| Previous Close | 1.2790 |
| Open | 1.3255 |
| Bid | 1.3360 x N/A |
| Ask | 1.3880 x N/A |
| Day's Range | 1.3255 - 1.3290 |
| 52 Week Range | 0.6500 - 6.2500 |
| Volume | |
| Avg. Volume | 108 |
| Market Cap | 18.053M |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.8120 |
| Earnings Date | Feb 08, 2023 - Feb 13, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.67 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for UDJP.F
Related Research
- Business Wire
Applied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based Vaccines
STONY BROOK, N.Y., January 05, 2023--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced the publication of a peer-reviewed research article in Molecular Therapy – Methods & Clinical Development. The study, titled ‘A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits protective immunity in domestic cats,’ supports the further development of the Company’s LinearDNA™ platform for the large-scale enzyma
- Insider Monkey
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2022 Earnings Call Transcript
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2022 Earnings Call Transcript December 16, 2022 Operator: Good afternoon, and welcome to the Applied DNA Sciences Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions . Please note […]
- Simply Wall St.
Applied DNA Sciences Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag
Applied DNA Sciences ( NASDAQ:APDN ) Full Year 2022 Results Key Financial Results Revenue: US$18.2m (up 101% from FY...
